blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1390073

EP1390073 - COMPOSITIONS HAVING ENHANCED PHARMACOKINETIC CHARACTERISTICS [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  01.02.2013
Database last updated on 25.09.2024
Most recent event   Tooltip01.02.2013Refusal of applicationpublished on 06.03.2013  [2013/10]
Applicant(s)For all designated states
ALLERGAN, INC.
2525 Dupont Drive
Irvine, CA 92612 / US
[N/P]
Former [2004/09]For all designated states
Allergan, Inc.
2525 Dupont Drive
Irvine, California 92612 / US
Inventor(s)01 / WOODWARD, David, F.
22736 Islamare Lane
Lake Forest, CA 92630 / US
02 / AMBRUS, Gyorgy
12681 Swidler Place
Santa Ana, CA 92705 / US
 [2004/09]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastrasse 30
81925 München / DE
[N/P]
Former [2004/09]HOFFMANN - EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Application number, filing date02725939.903.05.2002
[2004/09]
WO2002US14241
Priority number, dateUS2001084793503.05.2001         Original published format: US 847935
US2002013624001.05.2002         Original published format: US 136240
[2004/09]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO02089853
Date:14.11.2002
Language:EN
[2002/46]
Type: A2 Application without search report 
No.:EP1390073
Date:25.02.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 14.11.2002 takes the place of the publication of the European patent application.
[2004/09]
Search report(s)International search report - published on:EP11.12.2003
ClassificationIPC:A61K47/48, A61P27/06
[2004/09]
CPC:
A61K47/58 (EP); A61K31/498 (EP); A61K47/542 (EP);
A61P27/06 (EP); A61P3/10 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/09]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ZUSAMMENSETZUNGEN MIT VERBESSERTEN PHARMAKOKINETISCHEN EIGENSCHAFTEN[2004/09]
English:COMPOSITIONS HAVING ENHANCED PHARMACOKINETIC CHARACTERISTICS[2004/09]
French:COMPOSITIONS AYANT DES CARACTERISTIQUES PHARMACOCINETIQUES AMELIOREES[2004/09]
Entry into regional phase31.10.2003National basic fee paid 
31.10.2003Designation fee(s) paid 
31.10.2003Examination fee paid 
Examination procedure27.11.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
31.10.2003Examination requested  [2004/09]
10.10.2006Despatch of a communication from the examining division (Time limit: M04)
24.01.2007Reply to a communication from the examining division
04.10.2007Despatch of a communication from the examining division (Time limit: M06)
14.04.2008Reply to a communication from the examining division
18.09.2012Cancellation of oral proceeding that was planned for 09.10.2012
02.10.2012Despatch of communication that the application is refused, reason: substantive examination [2013/10]
09.10.2012Date of oral proceedings (cancelled)
12.10.2012Application refused, date of legal effect [2013/10]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.10.2006
Fees paidRenewal fee
24.05.2004Renewal fee patent year 03
19.05.2005Renewal fee patent year 04
30.05.2006Renewal fee patent year 05
30.05.2007Renewal fee patent year 06
28.05.2008Renewal fee patent year 07
27.05.2009Renewal fee patent year 08
25.05.2010Renewal fee patent year 09
25.05.2011Renewal fee patent year 10
25.05.2012Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9744063  (NEUROMEDICA INC [US]) [X] 1-72 * page 19, line 23; claim 1 *;
 [PX]US6255502  (PENKLER LAWRENCE JOHN [ZA], et al) [PX] 1 * claim - *;
 [PX]US2001056116  (SHASHOUA VICTOR [US]) [PX] 1 * sentence 083; claim 1 *;
 [PA]WO0205853  (ALLERGAN SALES INC [US], et al) [PA] 1 * claim - *;
 [E]WO02089804  (ALLERGAN INC [US]) [E] 1-72* claim - *
ExaminationJPH11130656
 US4188393
 US4629621
 EP0305726
 EP0426390
 WO9802187
 US5811443
 WO0044355
 EP1392308
    - PATENT ABSTRACTS OF JAPAN, (19990831), vol. 1999, no. 10, & JP11130656 A 19990518 (KOSE CORP)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.